AVITA Medical (AVHHL) Work In Process (2021 - 2022)
AVITA Medical's (AVHHL) quarterly Work In Process came in at $384000.0 in Q4 2022, up 118.18% on a YoY basis from $176000.0 in Q4 2021, and up 118.18% quarter-over-quarter from $176000.0 in Q4 2021.
Powered by 
Analysis
AVITA Medical (AVHHL) Work In Process (2021 - 2022) Analysis & Trends
AVITA Medical (AVHHL) has reported Work In Process for 2 consecutive years, with $384000.0 the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Work In Process rose 118.18% year-over-year to $384000.0; the trailing twelve-month figure through Dec 2022 stood at $384000.0 (up 118.18% YoY), and the FY2022 full-year result was $384000.0, up 118.18% from the prior year.
- Work In Process advanced to $384000.0 in Q4 2022 per AVHHL's latest filing, from $176000.0 in the prior quarter.
- Across five years, Work In Process topped out at $384000.0 in Q4 2022 and bottomed at $176000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.89 Bn | 179.29 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.33 Bn | 119.12 Bn | 1.96 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn |
| 4 | Stryker | 104.48 Bn | 101.01 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.98 Bn | 66.44 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.79 Bn | 45.54 Bn | 1.35 Bn |
| 7 | Alcon | 33.96 Bn | 32.50 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 384,000.00 |
| Dec 31, 2021 | 176,000.00 |
| Jun 30, 2021 | 241,000.00 |